RE:RE:RE:RE:RE:Been here a while lurking We're all hoping that. Shareholders are hoping that and everyone at Theralase is hoping that. Theralase will stick to the Q4 submission milestone if they possibly can because it is in their interest to do so. It's in their interest to get BTD. It's in their interest to get FDA approval to commercialize a treatment for bladder cancer. And it's in their interest to accomplish this as soon as humanly possible.The delays so far have been beyond anyone's control.
The science is the easy part, making things happen in the real world is the hard part. Against all odds it looks like Theralase may pull this off. There are reasons behind the current communication situation and you would understand this if you were really a long and had been paying attention.
N0taP00p wrote: I'm just hoping there is no update that says we pushed everything out by X months for whatever reasons. The science seems to be solid and the doctors and scientists behind this seem to be solid as well. I just wish there was better and timely communications and good execution to build confidence and trust in that solid core. If anyone else thinks they're doing a wonderful job, fine by me. It's an opinion on a message board. I'm just hoping they stick to the Q4 submission milestone.